Get the Stockscreener App
175.37
0.01%
0.010
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $175.37, with a volume of 1.58M.
It is up +0.01% in the last 24 hours and up +28.36% over the past month.
Masimo Corp is a medical technology company. The company oepates in single segment namely Healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, and others.
See More
Previous Close:
$175.36
Open:
$175.35
24h Volume:
1.58M
Relative Volume:
1.29
Market Cap:
$9.16B
Revenue:
$1.53B
Net Income/Loss:
$207.70M
P/E Ratio:
-63.23
EPS:
-2.7734
Net Cash Flow:
$193.10M
1W Performance:
+0.15%
1M Performance:
+28.36%
6M Performance:
+22.63%
1Y Performance:
-4.41%
1-Day Range:
$175.29
$175.58
1-Week Range:
$175.13
$175.65
52-Week Range:
$125.94
$186.27
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
175.37 | 9.15B | 1.53B | 207.70M | 193.10M | -2.7734 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-17-25 | Initiated | BofA Securities | Neutral |
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Masimo Corporation $MASI Shares Sold by JPMorgan Chase & Co. - MarketBeat
Masimo (MASI) CFO Micah Young logs 15,000 RSU vesting and tax share withholding - Stock Titan
Joe Kiani Appointed to Scripps Research Board of Directors - Orange County Business Journal
Danaher to acquire Irvine-based Masimo - Irvine Standard
Joe Kiani’s Patient Safety Foundation Holds 12th Annual Summit - Orange County Business Journal
Masimo Corporation $MASI Shares Sold by TD Asset Management Inc - MarketBeat
Masimo Corporation (NASDAQ:MASI) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Masimo Corporation $MASI Stock Position Boosted by Citigroup Inc. - MarketBeat
Masimo Corp. Experiences Evaluation Revision Amid Mixed Market Signals and Volatility - Markets Mojo
Decoding Masimo Corp (MASI): A Strategic SWOT Insight - GuruFocus
Danaher (NYSE: DHR) to acquire Masimo; MASI proxy materials sent to stockholders - Stock Titan
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Masimo Corporation (Nasdaq – MASI), IHS Holding Limited (NYSE – HIS), VerifyMe, Inc. (Nasdaq – VRME), Great Lakes Dredge & Dock Corporation (Nasdaq - ChartMill
Erste Asset Management GmbH Purchases 68,000 Shares of Masimo Corporation $MASI - MarketBeat
Where is Danaher Corporation (DHR) Headed? - Finviz
Masimo (MASI) CFO gets performance stock; 1,123 shares withheld for taxes - Stock Titan
Danaher Corporation Archives - Strata-gee.com
Masimo Acquired by Danaher: Is This the Conclusion to an Epic Saga? - Strata-gee.com
Danaher said to near $10 billion deal for Masimo, FT reports - MSN
Masimo earnings in focus as Danaher deal looms - Investing.com
Masimo Corporation $MASI Shares Bought by Westfield Capital Management Co. LP - MarketBeat
Envestnet Asset Management Inc. Sells 6,092 Shares of Masimo Corporation $MASI - MarketBeat
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KW, MASI, MCW, and JFB - Benzinga
MASI Technical Analysis & ETF Price Forecast - Intellectia AI
Danaher deal finalized: Company to acquire Masimo for $9.9 billion in cash - MSN
Uncovering Potential: Masimo's Earnings Preview - Benzinga
Earnings To Watch: Masimo (MASI) Reports Q4 Results Tomorrow - Yahoo Finance
Here's Why Masimo (MASI) is a Strong Momentum Stock - Yahoo Finance
Are MASI, THR, CECO Obtaining Fair Deals for their Shareholders? - Finviz
All-Cash Masimo Deal Offers Strong Strategic Fit For Danaher Corporation (DHR) - Finviz
Masimo Buyout By Danaher Spurs Revaluation And Volatility Questions - Yahoo Finance
Vanguard Group Inc. Has $709.72 Million Holdings in Masimo Corporation $MASI - MarketBeat
Masimo Set to Join Beckman Owner, Danaher, in $9.9 Billion Deal - Orange County Business Journal
Danaher to acquire Masimo for $9.9 billion - DOTmed
Jupiter Asset Management Ltd. Acquires New Shares in Masimo Corporation $MASI - MarketBeat
Taxation With Representation: Freshfields, Simpson Thacher - Law360
Danaher Drops $10B to Snatch Masimo in Diagnostics Push - Dealbreaker
Danaher to Acquire Masimo Corp. for $9.9B | Business | Feb 2026 - Photonics Spectra
Here's Why Masimo (MASI) is a Strong Growth Stock - Yahoo Finance
Danaher to Acquire Masimo in Transaction Valued at $9.9 Billion - Sleep Review
Danaher to buy medical tech firm Masimo for $9.9 billion - MSN
Masimo's Board Backs Danaher's $9.9B Cash Acquisition Proposal - Finviz
Danaher to Acquire Masimo in $9.9 Billion Deal - National Today
Danaher’s $9.9 Billion Acquisition of Masimo: A Strategic Pivot to the Future of Patient Monitoring - The Chronicle-Journal
Claim your share of the $33.75M Experience Masimo securities class action settlement - Claim Depot
Masimo (MASI) climbs 34% on $9.9-billion Danaher merger - MSN
Masimo to be acquired by Danaher for $180.00 per share - MSN
Masimo agrees $10BN Danaher switch - Optics.org
Masimo (MASI) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Masimo Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo CorporationMASI - Barchart.com
Danaher moves to acquire Masimo in $9.9bn deal - Life Sciences Intellectual Property Review
Danaher's Masimo Acquisition: Solid Financials, Conservative Growth Projections - Benzinga
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.27%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):